Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: one or two weeks?

Dal Bo', N; Di Mario, F; Battaglia, G; Buda, A; Leandro, G; Vianello, F; Kusstatscher, S; Salandin, S; Pilotto, A; Cassaro, M; Vigneri, S; Rugge, M

Dal Bo', N; Di Mario, F; Battaglia, G; Buda, A; Leandro, G; Vianello, F; Kusstatscher, S; Salandin, S; Pilotto, A; Cassaro, M; Vigneri, S; Rugge, M.

Affiliation

Dal Bo' N; Istituto di Medicina Interna, Cattedra Malattie Apparato digerente, Università degli Studi di Padova, Italy.

J Gastroenterol Hepatol ; 13(3): 288-93, 1998 Mar.

Article in En | MEDLINE | ID: mdl-9570242

Subject(s)

Clarithromycin/administration & dosage; Helicobacter Infections/drug therapy; Helicobacter pylori; Adult; Aged; Aged, 80 and over; Clarithromycin/adverse effects; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pilot Projects; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Helicobacter pylori / Helicobacter Infections / Clarithromycin Type of study: Clinical_trials / Guideline Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 1998 Document type: Article Affiliation country: Italy Country of publication: Australia

Search on Google

Add to My VHL

XML

PubMed Links